novorapid flexpen
novo nordisk pharmaceuticals ltd - insulin aspart 100 iu/ml; - solution for injection - 100 iu/ml - active: insulin aspart 100 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as chloride - the treatment of diabetes mellitus
novorapid
novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml; - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the chloride - the treatment of diabetes mellitus.
novoseven rt
novo nordisk pharmaceuticals ltd - eptacog alfa (activated) 1mg - powder for injection with diluent - 1 mg - active: eptacog alfa (activated) 1mg excipient: calcium chloride dihydrate glycylglycine mannitol methionine nitrogen polysorbate 80 sodium chloride sucrose histidine water for injection - indicated for the control of bleeding and surgical prophylaxis in patients: · with inhibitors to coagulation factors viii or ix · with congenital fvii deficiency · with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions
novoseven rt
novo nordisk pharmaceuticals ltd - eptacog alfa (activated) 2mg - powder for injection with diluent - 2 mg - active: eptacog alfa (activated) 2mg excipient: calcium chloride dihydrate glycylglycine mannitol methionine nitrogen polysorbate 80 sodium chloride sucrose histidine water for injection - indicated for the control of bleeding and surgical prophylaxis in patients: · with inhibitors to coagulation factors viii or ix · with congenital fvii deficiency · with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions
novoseven rt
novo nordisk pharmaceuticals ltd - eptacog alfa (activated) 5mg - powder for injection with diluent - 5 mg - active: eptacog alfa (activated) 5mg excipient: calcium chloride dihydrate glycylglycine mannitol methionine nitrogen polysorbate 80 sodium chloride sucrose histidine water for injection - indicated for the control of bleeding and surgical prophylaxis in patients: · with inhibitors to coagulation factors viii or ix · with congenital fvii deficiency · with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions
novoseven rt
novo nordisk pharmaceuticals ltd - eptacog alfa (activated) 8mg; - powder for injection with diluent - 8 mg - active: eptacog alfa (activated) 8mg excipient: calcium chloride dihydrate glycylglycine mannitol methionine nitrogen polysorbate 80 sodium chloride sucrose histidine water for injection - indicated for the control of bleeding and surgical prophylaxis in patients: · with inhibitors to coagulation factors viii or ix · with congenital fvii deficiency · with glanzmann's thrombasthenia, who have antibodies to gpiib-iiia and/or hla, and with past or present refractoriness to platelet transfusions
novomix 30 penfill 3ml
novo nordisk pharmaceuticals pty ltd - insulin aspart -
novomix 30 flexpen 3ml
novo nordisk pharmaceuticals pty ltd - insulin aspart -
novorapid penfill 3ml
novo nordisk pharmaceuticals pty ltd - insulin aspart -
novorapid flexpen 3ml
novo nordisk pharmaceuticals pty ltd - insulin aspart -